At the NIH State-of-the-Science Conference a few weeks ago, an independent panel advised that active surveillance is appropriate for patients presenting low-grade, low-volume prostate cancer and...
(PRWeb February 03, 2012)
Read the full story at http://www.prweb.com/releases/2012/2/prweb9167112.htm